A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects

Clinical trial NCT07185113 · COMPLETED

Trial details

NCT number: NCT07185113
Sponsor: GEn1E Lifesciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male

Start date: 2025-10-29
Primary completion: 2025-11-04
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.